Are electrolytes safe with Wegovy and Mounjaro
& Kansteiner, F
A comprehensive solution pairs high-quality, compounded medications with a GLP-1 meal plan , creating a powerful program for lasting, healthy lifestyle change.
In major clinical trials, participants lost about 5% of their starting body weight in the first 12 weeks, with continued progress for 6 months to a year
Future directions and research priorities Future research should prioritize well-controlled human intervention studies integrating GLP-1based pharmacotherapy with defined postbiotic preparations, with explicit assessment of body composition, lean mass preservation, and post-discontinuation weight trajectories
In conclusion, GLP-1 medications like semaglutide can coexist with IBS, and with the right approach, patients can achieve their weight management goals without derailing their digestive health